Shardul Amarchand Mangaldas & Co. advises Nephrocare Health Services Limited on its Initial Public Offering
Shardul Amarchand Mangaldas advised Nephrocare Health Services Limited (Nephroplus) on its initial public offering aggregating to approximately US$ 95.99 million, covering Indian law, regulatory compliance, and prospectus and listing support.
